Lysoganglioside derivatives
    23.
    发明授权
    Lysoganglioside derivatives 失效
    溶血二糖苷衍生物

    公开(公告)号:US06407072B1

    公开(公告)日:2002-06-18

    申请号:US08268730

    申请日:1994-06-30

    IPC分类号: A61K3170

    CPC分类号: C07H15/10

    摘要: Novel N-acyl-lysogangliosides obtained from gangliosides by deacyation of the ceramide group, wherein the acyl group is derived from an aliphatic acid having from 2 to 24 carbon atoms, substituted by one or more polar groups. The N-acyl-lysogangliosides of the invention exhibit an inhibiting action on protein-kinase C activation and, thus, can be utilized in therapies for various pathologies of the nervous system.

    摘要翻译: 通过神经酰胺基去酰化从神经节苷脂获得的新型N-酰基 - 溶血杆菌二糖苷,其中酰基衍生自具有2至24个碳原子的脂族酸,被一个或多个极性基团取代。 本发明的N-酰基 - 溶血杆菌二糖苷对蛋白激酶C活化具有抑制作用,因此可用于神经系统各种病理学的治疗。

    Semisynthetic ganglioside analogues
    28.
    发明授权
    Semisynthetic ganglioside analogues 失效
    半合成神经节苷脂类似物

    公开(公告)号:US5484775A

    公开(公告)日:1996-01-16

    申请号:US96853

    申请日:1993-07-26

    CPC分类号: C07H15/10

    摘要: N-acyl-N,N'-dilysogangliosides, wherein the acyl groups are derived from unsubstituted aliphatic acids having from 1 to 11 carbon atoms, and N'-acyl-N,N'-dilysogangliosides and N,N'-di-acyl-N,N'-dilysogangliosides, in which the acyl groups are derived from unsubstituted aliphatic acids having from 1 to 24 carbon atoms (with the exception of certain acetyl and diacetyl derivatives). The compounds of the invention exhibit an inhibiting action on protein kinase C activation and, thus, can be utilized in therapies for various pathologies of the nervous system. Pharmaceutical compositions and therapeutic utilities for the lysoganglioside derivatives are also disclosed.

    摘要翻译: N-酰基-N,N'-二糖二糖二糖苷,其中酰基衍生自具有1至11个碳原子的未取代的脂族酸,和N' - 酰基-N,N'-二糖二糖二糖苷和N,N'-二酰基 其中酰基衍生自具有1至24个碳原子的未取代的脂族酸(除了某些乙酰基和二乙酰基衍生物)。 本发明的化合物对蛋白激酶C活化具有抑制作用,因此可用于治疗神经系统的各种病理学。 还公开了溶血二糖苷衍生物的药物组合物和治疗用途。